David Cobrinik, MD, PhD News

Originally training in ballet, Kayla Stepanian took on a role at CHLA and is now a Research Specialist working on research into inherited retinal diseases.

CHLA has been at the forefront of retinoblastoma research for decades. Cobrinik was invited to review the current state of retinoblastoma research.

A fifth-year PhD student, Kevin is studying patterns of genetic mutation in retinoblastoma.

Linda is hoping that her research will eventually lead to a first-of-its-kind test to detect osteosarcoma at its earliest stages.

Paige Berger, PhD, RD Paige is a postdoctoral research fellow studying early nutrition and brain development. “I’ve always been interested in the interplay between nutrition and exercise—the use of

The Stem Cell Analytics Core facilitates stem cell research and innovation for all investigators at CHLA.

Amber Medina Clinical Research Coordinator Amber helps coordinate leukemia and lymphoma trials. Though she has been doing clinical research for 15 years, Amber came to CHLA just two years ago. Joining

Microscopic image: MDM2 expression (in red) in retinoblastoma Rb176 cells. Credit: Donglai Qi, PhD, and David Cobrinik, MD, PhD. Researchers at The Saban Research Institute of Children’s Hospital Los

Retinoblastoma is a common eye cancer in children. David Cobrinik of The Vision Center has helped answer the question of why mutations to the RB1 gene primarily cause tumors of the retina.